Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
基本信息
- 批准号:10772738
- 负责人:
- 金额:$ 1.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholinesteraseAcetylcholinesterase InhibitorsAcuteAdaptor Signaling ProteinAdministrative SupplementAgeCause of DeathCessation of lifeChemical WeaponsChronicComplexDrug TargetingElementsEnvironmental HealthEnzymesExposure toGoalsImpairmentIn VitroInsecticidesInternshipsMuscleMuscle ContractionMuscular AtrophyNervous System TraumaOrganophosphatesOximesParathionPesticidesPhosphorylationProtein KinaseProtein Kinase InteractionProteinsPublishingRecoveryRefractoryResearchResistanceRetro-Inverso PeptideSarinSeizuresSiteSmall RNAStudentsSurfaceSynapsesTherapeuticToxic effectUnited Statesagedblood-brain barrier permeabilizationcholinergicdrug discoveryhealth science researchhigh schoolin vivoinnovationinsightnerve agentneuromuscularneurotoxicityneurotransmissionnovel strategiesparent grantpeptidomimeticspostsynapticprotein complexprotein protein interactionsummer internshiptoxic organophosphate insecticide exposure
项目摘要
Project Summary.
This administrative supplement will introduce environmental health sciences research to a summer high school
intern. Organophosphate (OP) insecticides (e.g., Naled, parathion) and chemical weapons (e.g., sarin, VX,
Novichok) are robust inhibitors of acetylcholinesterase (AChE) triggering cholinergic crises resulting in muscle
contractions, seizures, and in extreme exposures death. Certain OPs can rapidly (within minutes) irreversibly
inhibit AChE, producing an “aged” species refractory to oxime reactivators, like 2-pralidoxime (2-PAM), which is
part of the OP treatment in the United States and whose efficacy has recently been questioned. Consequently,
there is an urgent need to discover novel approaches to rescue AChE activity following OP exposure to mitigate
the damaging neurological and muscular effects. The long-term goal of the proposed research is to develop
viable, lasting treatments for acute and chronic OP exposures. Previous efforts to rescue aged AChE have
focused on producing new reactivators that will alkylate the phosphorylated enzyme allowing oximes like 2-PAM
to recover enzyme function, but these compounds have shortcomings such as insufficient blood-brain barrier
permeability and limited efficacy in vivo. The proposed research is innovative because it employs strategies
aimed at increasing the turnover aged AChE and recovery of nascent intracellular AChE. For example, inhibiting
or loss of muscle-specific protein kinase (MuSK) destabilizes the AChE complex leading to the degradation of
the enzyme. Recent studies demonstrate that Dok7, an adaptor protein in the AChE complex, is necessary for
MuSK activity and more importantly, AChE localization on the muscle surface. Therefore, the current research
objective is to assess whether targeting proteins in the synaptic AChE complex can increase AChE turnover and
restore optimal AChE activity. The central hypothesis in pursuit of this objective is that inhibiting or degrading
proteins associated with aged AChE will cause the release of the aged enzyme, making way for new AChE to
repopulate the synapse, restore optimal neurotransmission, and mitigate the effects of OP exposures. The
rationale for the proposed research is that eliminating aged AChE will alleviate the detrimental effects of OP
toxicity and restore proper neurotransmission. Based on published and preliminary studies, the high school intern
will investigate elements in Specific Aim 1 of the parent grant: Evaluate the in vitro therapeutic benefit of targeting
proteins in the AChE complex for degradation. In the proposed project, the high school intern will use small RNAs
to diminish the protein levels of Dok7. Similarly, the student will use a retro-inverso peptide mimicking the Dok7-
MuSK interaction site to destabilize the protein-protein interaction, which we hypothesize will result in the release
of aged AChE These studies will determine the druggability of Dok7 and determine if it will be evaluated as drug
discovery studies. This research is significant because it will provide fundamental mechanistic insights into the
stability and turnover of post-synaptic AChE complexes and unearth new targets to treat OP exposures.
项目总结。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy Wayne Chambers其他文献
Jeremy Wayne Chambers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy Wayne Chambers', 18)}}的其他基金
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
- 批准号:
10303546 - 财政年份:2021
- 资助金额:
$ 1.62万 - 项目类别:
相似海外基金
Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
- 批准号:
10739853 - 财政年份:2023
- 资助金额:
$ 1.62万 - 项目类别: